1. Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac). (April 2016) Authors: Meijer, L.L.; Garajová, I.; Caparello, C.; Le Large, T.Y.S.; Funel, N.; Vasile, E.; Giovannetti, E.; Zonderhuis, B.M.; Daams, F.; Kazemier, G. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma. (2019) Authors: Meijer, L.; Garajová, I.; Caparello, C.; Le Large, T.; Funel, N.; Vasile, E.; Zonderhuis, B.; Daams, F.; Giovannetti, E.; Kazemier, G. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating microRNAs discriminate cholangiocarcinoma from pancreatic cancer. (September 2018) Authors: Meijer, L.L.; Puik, J.R.; Le Large, T.Y.S.; Heger, M.; Dijk, F.; Funel, N.; Garajová, I.; Giovannetti, E.; Kazemier, G. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer?. Issue 7 (15th October 2013) Authors: Muller, I.; Giani, C.; Zhang, L.; Grennan‐Jones, F.A.; Fiore, E.; Belardi, V.; Rosellini, V.; Funel, N.; Campani, D.; Giustarini, E.; Lewis, M.D.; Bakhsh, A.D.; Roncella, M.; Ghilli, M.; Vitti, P.; Dayan, C.M.; Ludgate, M.E. Journal: International journal of cancer Issue: Volume 134:Issue 7(2014:Apr. 01) Page Start: 1706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phospho-Akt: a potential resistance marker to chemotherapy and therapy-target to restore sensitivity in pancreatic cancer. (February 2017) Authors: Giovannetti, E.; Massihnia, D.; Avan, A.; Funel, N.; Maftouh, M.; Van Krieken, A.; Granchi, C.; Raktoe, R.; Boggi, U.; Aicher, B.; Minutolo, F.; Russo, A.; Leon, L.; Peters, G. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phosphoproteome networks identify focal adhesion kinase as a new drug target that can be exploited in synergistic combination with paclitaxel. (2019) Authors: Le Large, T.; Bijlsma, M.; El Houssani, B.; Zonderhuis, B.; Daams, F.; Funel, N.; van Grieken, N.; Knol, J.; Piersma, S.; Pham, T.; Verheul, H.; van Laarhoven, H.; Jimenez, C.; Giovannetti, E.; Kazemier, G. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Platelet RNA yields a new diagnostic test for pancreatic cancer: a multicenter cohort. (September 2018) Authors: Le Large, T.; Meijer, L.L.; Veld, S.G.J.G. in 't; Best, M.; Funel, N.; Bijlsma, M.F.; Besselink, M.; Giovannetti, E.; Wurdinger, T.; Kazemier, G. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗